USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Orpyx Medical Technologies Inc.

USPTO PatentsView assignee record — 21 granted patents across 20 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

21
Total patents granted
20
CPC technology areas
17.9
Avg claims per patent
+325%
5-year filing velocity

Portfolio overview

Orpyx Medical Technologies Inc. has been granted 21 US utility patents between 2015 and 2025, placing Orpyx Medical Technologies Inc. at rank #14,193 across all assignees tracked by PlainPatent. This portfolio spans 20 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.9 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, Orpyx Medical Technologies Inc. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 57.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 17 grants, compared with 4 in the 2015–2019 window — a +325% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Orpyx Medical Technologies Inc.'s 17.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 20 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Orpyx Medical Technologies Inc. against peers pursuing similar technology classes.

How does Orpyx compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Orpyx holds 21 patents — placing it at rank #14,193 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2025

0123456 20152017201820212022202320242025 5
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Orpyx Medical Technologies Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 1 4.8%
2017 1 4.8%
2018 2 9.5%
2021 2 9.5%
2022 3 14.3%
2023 5 23.8%
2024 2 9.5%
2025 5 23.8%

Which technologies does Orpyx Medical Technologies Inc. patent most?

Top 15 of 20 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Accelerating

Where it ranks

Overall rank by patents

#14,193

Across all tracked assignees

Innovation Score

57.3 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Orpyx Medical Technologies Inc. hold?
Orpyx Medical Technologies Inc. holds 21 US granted patents filed between 2015 and 2025, spanning 20 technology areas.
What is Orpyx Medical Technologies Inc.'s Innovation Score?
Orpyx Medical Technologies Inc. has an Innovation Score of 57.3 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Orpyx Medical Technologies Inc. focus on?
Orpyx Medical Technologies Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 12 patents. The company has filed patents in 20 CPC subclasses total.
Is Orpyx Medical Technologies Inc.'s patent filing rate increasing or decreasing?
Orpyx Medical Technologies Inc.'s recent filing velocity is +325% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Orpyx Medical Technologies Inc.'s patents?
Orpyx Medical Technologies Inc.'s patents average 17.9 claims each. This falls within the standard range, providing solid legal coverage.
How is the Orpyx Medical Technologies Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope